People Moves

RSS | Login | Register

People news: Kantar Health, NeurOp

April 16, 2012

Healthcare consultancy firm, Kantar Health, has promoted two TNS healthcare alumni, NeurOp appoints first CSO.

People news: Optimer Therapeutics and Johnson & Johnson

April 09, 2012

Michael Chang, chairman of the board at Optimer Therapeutics and Optimer Biotechnology, was removed due to compliance/conflict of interest issues, Optimer said. Chang's replacement on the Optimer board is Hank McKinnell, former CEO of Pfizer.

Company news: Epocrates, Chandler Chicco

April 03, 2012

Andrew Hurd is the new CEO and president of medical information platform developer Epocrates,

People news: Harrison & Star, LLNS

March 20, 2012

Mardene Miller has been named president of the Omnicom's healthcare agency Harrison and Star.

People moves: Alkermes and Euro RSCG Life UK

March 06, 2012

Alkermes appointed its first chief commercial officer, Merck veteran Mark Stejbach.

People news: Novartis, Qforma and Precision Health Media

March 01, 2012

Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.

People news: Elsevier and Ogilvy CommonHealth

February 14, 2012

Elsevier named Jay Katzen managing director for its Clinical Decision Support group.

People news: HBA, Cardinal Health, PhRMA and Publicis Touchpoint

February 07, 2012

The Healthcare Businesswomen's Association named Cardinal Health pharma segment chief Michael Kaufmann as its 2012 Honorable Mentor of the year.

People news: Siren, HBA and GreenLeaf Health

January 26, 2012

The Healthcare Businesswomen's Association named Siren Interactive founder and president Wendy White to its board of directors executive committee.

People news: Teva

January 03, 2012

Teva named former Bristol-Myers Squibb exec Dr. Jeremy Levin to replace Shlomo Yanai, who is retiring from his role as president and CEO of the generics giant in May.

People news: Vertex and Amgen

December 22, 2011

Vertex CEO Matthew Emmens is stepping down from that post after the company's best year ever and amid skyrocketing sales of its hepatitis C drug Incivek.

People news: Pfizer

December 13, 2011

Pfizer's board of directors elected CEO Ian Read chairman, succeeding George Lorch in that post.

People news: Auxilium Pharmaceuticals and Essentialis

December 08, 2011

Adrian Adams was appointed CEO and president of Auxilium Pharmaceuticals, effective immediately, succeeding Armando Anido, who, after discussions with the company's board agreed to step down from that role.

People news: Pfizer

November 29, 2011

Brian McGowan, Pfizer's senior director of education, oncology, in the medical education grants group, said he is leaving the company tomorrow.

People News: Genzyme and AccentHealth

November 10, 2011

Genzyme named William "Bill" Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare diseases, two businesses the firm says constitute its core focus following the integration with Sanofi.

People news: POGO and Everyday Health

Matthew Arnold November 03, 2011

Muckraking pharma critic Paul Thacker is leaving the Project on Government Oversight, where he has been an investigator for a year since leaving the Senate, to serve as chief of investigations at United Republic.

People news: Lilly, J&J and Merck

October 11, 2011

Lilly named Lilly USA president Dave Ricks SVP and president of Lilly Bio-Medicines, in which role he'll succeed Bryce Carmine, who is retiring.

People news: Boston Scientific and Elan

September 15, 2011

Boston Scientific named J&J devices chief Michael Mahoney president and, eventually, CEO.

People News: Sunovion Pharmaceuticals, ImpactRx

August 30, 2011

Sunovion Pharmaceuticals has announced that Mark Iwicki, formerly president and chief operating officer at Sunovion, has been appointed as the company's president and CEO.

People News: Sunovion Pharmaceuticals, ImpactRx

August 30, 2011

Sunovion Pharmaceuticals has announced that Mark Iwicki, formerly president and chief operating officer at Sunovion, has been appointed as the company's president and CEO.

Subscribe to the RSS for this page [view all our RSS feeds here]

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.